Flex Biomedical's Debt Round

Flex Biomedical raised a round of funding on August 11, 2009. Investors include Wisconsin Technology Venture Fund.

Flex Biomedical is developing technologies to treat and diagnose orthopedic diseases. Flex Biomedical's lead product is a synthetic polymer, the Flex Polymer, designed to treat osteoarthritis.…

Articles about Flex Biomedical's Debt Round: